SCHEMBL13302829

SCHEMBL13302829

O=C1NC2=C(C(=O)OC2)C(c2ccccc2)N1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
ALDH1A1 P00352 7/20 0.51
MAPT P10636 5/20 0.51
MAPK10 P53779 1/20 0.51
KDM4E B2RXH2 4/20 0.48
BRD4 O60885 3/20 0.45
USP2 O75604 1/20 0.44
HTT P42858 2/20 0.43
POLB P06746 1/20 0.43
BRDT Q58F21 2/20 0.43
ABCC9 O60706 1/20 0.42
ABCC8 Q09428 1/20 0.42
KCNJ11 Q14654 1/20 0.42
KCNJ8 Q15842 1/20 0.42
LMNA P02545 2/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13302814 0.84 ALDH1A1 (0.59) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL13425478 0.83 MEN1 (0.55) MEN1KMT2AALDH1A1MAPTMAPK10
SCHEMBL7095756 0.78 ABCC9 (0.58) ALDH1A1MAPTKDM4EBRD4HTT
SCHEMBL29044382 0.74 MAPT (0.73) MEN1KMT2AALDH1A1MAPTMAPK10
SCHEMBL15976552 0.73 ALDH1A1 (0.74) MEN1KMT2AALDH1A1MAPTMAPK10
SCHEMBL13302828 0.73 KMT2A (0.50) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL395878 0.71 TDP1 (0.66) KMT2AALDH1A1MAPTMAPK10KDM4E
SCHEMBL19955179 0.71 TDP1 (0.66) KMT2AALDH1A1MAPTMAPK10KDM4E
SCHEMBL31738422 0.71 TDP1 (0.66) KMT2AALDH1A1MAPTMAPK10KDM4E
SCHEMBL16424678 0.71 BRD4 (0.61) MEN1KMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof KIF5A, KIF5C, KIF5B MEN1 2916/4885KMT2A 1008/4885ALDH1A1 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.